Cancer Treatment - successful immunotherapy PD-1 inhibitors

In recent years, scientists have a lot of emphasis on the development of new methods for the treatment of malignant neoplasms. Along with cytostatic treatment, which are not completely differentiated affect all dividing cells and antibody treatment today kinase inhibitors, specifically blocking the metabolism of cancer cells are not uncommon.
The newest trend in cancer treatment is immunotherapy. Substances such Ipalimumabu (Ipalimumab), introduced in 2011, did not have a direct effect on the tumor and cause the immune response of the whole organism to tumor development. Such a method gives very good results in the treatment of melanoma. The most modern version of such immunotherapy - is the use of kinase inhibitors. PD-1 - is a membrane protein of the immunoglobulin family, plays an important role in cell differentiation of immune cells. Similar preparations - Nivolumab (Nivolumab) and Pembrolizumab (Pembrolisumab) showed good results in the treatment of various tumors. Pembrolizumab in September this year has been approved for use in the United States for the treatment of melanoma, and soon to be received permission for its introduction in Europe.
The studies on the effects on cancer cells with stem cells which are pre-fitted with a bacterial toxin gene.
Another group of scientists using the method of "bacteriological surgery" tried to prove that the introduction of anaerobic bacteria is to destroy the center of the tumor, without bringing harm to the patient.
In this way have been reduced metastases in a patient with leiomyosarcoma.

Return
Treatment on-line cost calculation
Calculate